Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: The Wellcome Foundation Ltd., 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom Trading as: GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Zovirax I.V. 250 mg.
Zovirax I.V. 500 mg.
| Pharmaceutical Form |
|---|
|
Intravenous injection. |
250 mg aciclovir or 500 mg aciclovir in each vial.
Excipients with known effect: Sodium hydroxide
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Aciclovir |
Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation. |
| List of Excipients |
|---|
|
Sodium hydroxide (used to adjust pH) |
Type I glass vials closed with butyl or bromobutyl rubber stoppers secured by aluminium collars.
17 ml-nominal capacity of vial containing 250 mg aciclovir.
25 ml-nominal capacity of vial containing 500 mg aciclovir.
The Wellcome Foundation Ltd., 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Trading as: GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex, UB11 1BT
PL 00003/0159
Date of first authorisation: 6 April 1982
Date of last renewal: 9 June 1997
| Drug | Countries | |
|---|---|---|
| ZOVIRAX | Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
